International Journal of Molecular Sciences · 2023 · 13 citations · 35 references
MedicineOncologyPharmacologyBiomedical OpticsDrug DeliveryMolecular ImagingPhotochemistryPhotodynamic TherapyTargeted Imaging AgentsTumor ImagingCancer Photodynamic TherapyPhotosensitizersPhotosensitizing CompoundsTumor Selectivity
Photodynamic therapy has emerged as a recognized anti-tumor treatment involving three fundamental elements: photosensitizers, light, and reactive oxygen species. Enhancing the effectiveness of photosensitizers remains the primary avenue for improving the biological therapeutic outcomes of PDT. Through three generations of development, HPPH is a 2-(1-hexyloxyethyl)-2-devinyl derivative of pyropheophorbide-α, representing a second-generation photosensitizer already undergoing clinical trials for various tumors. The evolution toward third-generation photosensitizers based on HPPH involves structural modifications for multimodal applications and the combination of multifunctional compounds, leading to improved imaging localization and superior anti-tumor effects. While research into third-generation HPPH is beneficial for advancing PDT treatment, equal attention should also be directed toward the other two essential elements and personalized diagnosis and treatment methodologies.
35
Renal clearance of quantum dots
Hak Soo Choi, Wenhao Liu, Preeti Misra et al. · Nature Biotechnology · 2007 · 4.4K citations · Full text
ADMET-score – a comprehensive scoring function for evaluation of chemical drug-likeness
Longfei Guan, Hongbin Yang, Yingchun Cai et al. · MedChemComm · 2018 · 694 citations
Lu Zhang, Shuangshuang Wan, Chu‐Xin Li et al. · Nano Letters · 2018 · 586 citations